HIGHLIGHTS
- who: J. Clin. Med. and colleagues from the Bordeaux Population Health Research Center, ISPED, University of Bordeaux, Bordeaux, Department of Neurosurgery, Centre Hospitalier Universitaire Bordeaux, Bordeaux have published the Article: Clinical Medicine Important: Candidate Treatment for COVID-19?, in the Journal: (JOURNAL) of 15/08/2020
- what: The authors evaluate the effect of coffee's active part 1 3 7-trimethylxanthine (TMX) on patients with COVID-19. The aim of this study was not to prove the efficacy of coffee but to reveal how anyone can prove anything with a non-rigorous study.
SUMMARY . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.